AstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Lawsuit Overview - The lawsuit alleges that AstraZeneca failed to disclose its involvement in insurance fraud in China, leading to heightened legal exposure and the detention of its China President by Chinese authorities [3] - The company is accused of understating its legal risks, which could materially harm its business activities in China [3] - Defendants' positive statements about the company's business, operations, and prospects are claimed to be materially misleading and/or lacking a reasonable basis [3] Legal Action Details - Investors who suffered losses in AstraZeneca PLC (AZN) have the opportunity to lead the securities fraud class action lawsuit [1] - The deadline for lead plaintiff participation is February 21, 2025 [2] - Investors can contact the Law Offices of Howard G. Smith to discuss their legal rights and participate in the lawsuit [2][4] Class Action Participation - Investors do not need to take any action to be a member of the class action; they may retain counsel of their choice or remain an absent member [5] - The press release may be considered Attorney Advertising in some jurisdictions under applicable law and ethical rules [5]